RxDoctor Payments Data

Franklin Baker, PA

Medical · Chattanooga, TNNPI 1740439462

Payments from drug & device makers

$1,036in general payments, 2019–2025

Across 54 payments — averaging $19.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$235
  • AbbVie$157
  • GSK$132
  • Pfizer$100
  • Abbott$92
  • Otsuka America Pharmaceutical, Inc.$55
  • plus $265 from 10 others

What the payments were for

  • Food & beverage$1,02399%
  • Entertainment$141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,036 in reported general payments places this provider in the 60th percentile of 480 medical providers in Tennessee.

See all medical providers in Tennessee

Medicare billing

Part B allowed, 2024
$38,060
Medicare patients
112
Services billed
1,007

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide27$49,646
MounjaroTirzepatide38$45,989
JardianceEmpagliflozin32$41,106
XareltoRivaroxaban11$17,126
Rosuvastatin Calcium115$2,064
Ezetimibe33$1,997
Potassium Chloride33$1,844
Atorvastatin Calcium77$1,142
SynthroidLevothyroxine Sodium11$1,033
Olmesartan Medoxomil44$872
Chlorthalidone30$833
Bupropion XlBupropion Hcl21$811
Ibandronate Sodium20$809
Buspirone Hcl19$766
Tamsulosin Hcl44$701

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$235$49,64627 claims
Lilly USA, LLCMounjaro$27$45,98938 claims
Johnson & JohnsonXarelto$32$17,12611 claims
AbbVieSynthroid, Armour Thyroid$157$1,67526 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 480 medical providers in Tennessee.

Other medical in Chattanooga

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →